Wynik wyszukiwania w bazie Polska Bibliografia Lekarska GBL

Zapytanie: DĄBROŚ
Liczba odnalezionych rekordów: 2



Przejście do opcji zmiany formatu | Wyświetlenie wyników w wersji do druku
1/2

Tytuł oryginału: The influence of a new vanadium compound, Bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver Golgi complexes from control and streptozotocin-diabetic rats.
Autorzy: Kordowiak A. M., Dąbroś W., Kajda B.
Źródło: Horm. Metab. Res. 2002: 34 (10) s.556-560, il., tab., bibliogr. 32 poz.
Sygnatura GBL: 312,226

Hasła klasyfikacyjne GBL:
  • endokrynologia
  • farmacja

    Typ dokumentu:
  • praca doświadczalna
  • praca opublikowana za granicą
  • tytuł obcojęzyczny

    Wskaźnik treści:
  • zwierzęta
  • szczury
  • płeć żeńska

    Streszczenie angielskie: Among the previously studied organic vanadium derivatives showing anti-diabetic action, we investigated a new complex, bis(2,2'-bipyridine)oxovanadium(IV) sulphate. We tested its ability to normalise parameters previously described for streptozotocin (STZ)-diabetes, such as lower yields of Golgi-rich membrane fraction isolation, decreased activity of Golgi membrane marker enzyme - galactosyltransferaze(GalT) - and altered morphology of rat liver Golgi complexes. Oral application as a drinking solution of 1,8 mmol bis(2,2'-bipyridine)oxovanadium(IV) (dissolved in 0.09 M NaCl) caused a similar dispersion of GalT activities in both vanadium treated groups, control and diabetic. Very low activities of the enzyme (characteristic for untreated diabetes) we found only in approximately 35 p.c. of the STZ-diabetic rats treated with the new vanadium compound. The morphology of liver Golgi complexes in diabetic rats treated with bis{2,2'-bipyridine)oxovanadium(IV) sulphate was improved, which manifested itself in the reappearance of vacuoles with VLDL and coated and uncoated secretory vesicles. In view of biochemical and morphological parameters of normalised diabetic rat liver Golgi apparatus, the new vanadium complex was more effective than bis(oxalato)oxovanadium(IV) or bis(kojato)oxovanadium(IV), but in our experimental model, the best anti-diabetic, orally applied drug was the bis(maltolato)oxovandium(IV) previously investigated.

    2/2

    Tytuł oryginału: The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
    Autorzy: Dąbroś Wojciech, Dziga Dariusz, Kordowiak Anna M.
    Źródło: Pol. J. Pathol. 2002: 53 (4) s.205-213, il., tab., bibliogr. 44 poz.
    Sygnatura GBL: 301,852

    Hasła klasyfikacyjne GBL:
  • toksykologia
  • endokrynologia
  • farmacja

    Typ dokumentu:
  • praca doświadczalna
  • tytuł obcojęzyczny

    Wskaźnik treści:
  • zwierzęta
  • szczury

    Streszczenie angielskie: The activity of galactosyltransferase (GalT), the Golgi apparatus marker enzyme, together with the morphology of this organelle in rat liver, are so characteristic that we have used them for twenty years as a test of streptozotocin-diabetes, and of the efficacy of different drugs. Bis-Maltolato)oxovanadium(IV) (BMOV), an oral vanadium complex with anti-diabetic properties, best of these drugs, was seen to reverse the previously found biochemical and morphological changes. Four groups of diabetic rats were studied in different conditions: 1) untreated diabetes (D group), 2) pre-treatment with BMOV for two days, to accustom the animals to the taste of vanadium solution and to verify possible cytoprotection of the drug, followed by the induction of diabetes c. 3 weeks later (pVD group). The third group - 3) consisted of the rats, in which STZ-diabetes was induced followed by treatment of diabetic animals with 1.8 mmol BMOV in 0.5 p.c. NaCl for seven days (D+V group). The fourth group - 4) consisted of the animals treated as pVD group, followed by induction of diabetes three weeks later and treatment with BMOV (pVD+V group) for seven days. In agreement with other invesitagtors, the reduction of body weight was seen in all diabetic rats. Vanadium treatment caused the greatest body weight reduction. Liquid and food intake was lower in both groups at seven days after treatment with VMOV. Major biochemical alterations in yields of Golgi-richi membrane fraction were found in D, pVD and pVD+V groups. They were signifcantly lowe (p 0.01) than in D+V group. A significantly lower acitvity...

    stosując format: